Commission Implementing Regulation (EU) 2023/1436 of 10 July 2023 concerning the non-renewal of the approval of the active substance dimoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/1436 of 10 July 2023 concerning the non-renewal of the approval of the active substance dimoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (Text with EEA relevance)

Preámbulo 1

recital 1recital 1

recital 2recital 2

recital 3recital 3

recital 4recital 4

recital 5recital 5

recital 6recital 6

recital 7recital 7

recital 8recital 8

recital 9recital 9

recital 10recital 10

recital 11recital 11

recital 12recital 12

recital 13recital 13

recital 14recital 14

recital 15recital 15

recital 16recital 16

recital 17recital 17

recital 18recital 18

recital 19recital 19

recital 20recital 20

recital 21recital 21

recital 22recital 22

Artículo 1Non-renewal of the approval of the active substance

Artículo 2Amendment to Implementing Regulation (EU) No 540/2011

Artículo 3Amendment to Implementing Regulation (EU) 2015/408

Artículo 4Transitional measures

Artículo 5Grace period

Artículo 6Entry into force

Citenza

Inteligencia jurídica con fuentes verificables, por Datons.

citenza.io